Silverarc Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$3.51M | – | 72 |
|
|
2024
Q1 | $3.51M | Buy |
+50,000
| New | +$3.51M | 0.97% | 32 |
|
|
2023
Q1 | – | Sell |
-17,500
| Closed | -$802K | – | 78 |
|
|
2022
Q4 | $802K | Buy |
+17,500
| New | +$802K | 0.23% | 64 |
|
|
2022
Q1 | – | Sell |
-58,190
| Closed | -$2.65M | – | 69 |
|
|
2021
Q4 | $2.65M | Buy |
58,190
+8,881
| +18% | +$405K | 1.07% | 30 |
|
|
2021
Q3 | $1.76M | Buy |
+49,309
| New | +$1.76M | 1% | 35 |
|